NORBERT G RIEDEL Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for NORBERT G RIEDEL.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of NORBERT G RIEDEL. NORBERT G RIEDEL is Corporate Vice President in BAXTER INTERNATIONAL INC ($BAX) and Senior Vice President in BAXTER INTERNATIONAL INC ($BAX) and Director in ARIAD PHARMACEUTICALS INC ($ARIA) and Director in Jazz Pharmaceuticals plc ($JAZZ) and CEO in Aptinyx Inc. ($APTX) and CEO and President in Aptinyx Inc. ($APTX) and Director in Eton Pharmaceuticals, Inc. ($ETON) and Director in Cerevel Therapeutics Holdings, Inc. ($ARYB).
Latest Insider Trading Transactions of NORBERT G RIEDEL
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, APTX, ARIA, BAX, CERE, ETON, JAZZ
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 26 2021 | APTX | Aptinyx Inc. | RIEDEL NORBERT G | CEO | Option Exercise | A | 3.80 | 733,300 | 2,786,540 | 733,300 | |
| Jan 06 2021 | ARYB | Cerevel Therapeuti ... | RIEDEL NORBERT G | Director | Option Exercise | M | 0.00 | 14,270 | 0 | 14,270 | |
| Jan 06 2021 | ARYB | Cerevel Therapeuti ... | RIEDEL NORBERT G | Director | Buy | M | 0.00 | 14,270 | 0 | 28,540 | 14.3 K to 28.5 K (+100.00 %) |
| Aug 10 2020 | JAZZ | Jazz Pharmaceutica ... | RIEDEL NORBERT G | Director | Option Exercise | A | 127.07 | 6,765 | 859,629 | 6,765 | |
| Aug 10 2020 | JAZZ | Jazz Pharmaceutica ... | RIEDEL NORBERT G | Director | Sell | S | 125.87 | 931 | 117,186 | 9,459 | 10.4 K to 9.5 K (-8.96 %) |
| Aug 10 2020 | JAZZ | Jazz Pharmaceutica ... | RIEDEL NORBERT G | Director | Grant | A | 0.00 | 2,705 | 0 | 10,390 | 7.7 K to 10.4 K (+35.20 %) |
| Mar 16 2020 | ETON | Eton Pharmaceutica ... | RIEDEL NORBERT G | Director | Option Exercise | A | 3.58 | 27,400 | 98,092 | 27,400 | |
| Mar 16 2020 | ETON | Eton Pharmaceutica ... | RIEDEL NORBERT G | Director | Option Exercise | A | 3.58 | 27,400 | 98,092 | 27,400 | |
| Jan 14 2020 | APTX | Aptinyx Inc. | RIEDEL NORBERT G | CEO and President | Buy | P | 3.00 | 35,000 | 105,000 | 35,000 | 0 to 35 K |
| Aug 12 2019 | JAZZ | Jazz Pharmaceutica ... | RIEDEL NORBERT G | Director | Option Exercise | A | 137.12 | 4,805 | 658,862 | 4,805 | |
| Aug 12 2019 | JAZZ | Jazz Pharmaceutica ... | RIEDEL NORBERT G | Director | Sell | S | 135.65 | 726 | 98,482 | 7,685 | 8.4 K to 7.7 K (-8.63 %) |
| Aug 12 2019 | JAZZ | Jazz Pharmaceutica ... | RIEDEL NORBERT G | Director | Grant | A | 0.00 | 1,920 | 0 | 8,411 | 6.5 K to 8.4 K (+29.58 %) |
| May 17 2019 | APTX | Aptinyx Inc. | RIEDEL NORBERT G | CEO and President | Option Exercise | A | 0.00 | 380,000 | 0 | 380,000 | |
| Mar 08 2019 | ETON | Eton Pharmaceutica ... | RIEDEL NORBERT G | Director | Option Exercise | A | 7.31 | 12,500 | 91,375 | 12,500 | |
| Jan 07 2019 | APTX | Aptinyx Inc. | RIEDEL NORBERT G | CEO and President | Option Exercise | A | 19.33 | 275,000 | 5,315,750 | 275,000 | |
| Nov 15 2018 | ETON | Eton Pharmaceutica ... | RIEDEL NORBERT G | Director | Buy | P | 6.00 | 5,000 | 30,000 | 59,745 | 54.7 K to 59.7 K (+9.13 %) |
| Sep 21 2018 | APTX | Aptinyx Inc. | RIEDEL NORBERT G | CEO and President | Option Exercise | A | 27.43 | 427,265 | 11,719,879 | 427,265 | |
| Aug 13 2018 | JAZZ | Jazz Pharmaceutica ... | RIEDEL NORBERT G | Director | Option Exercise | A | 177.73 | 3,735 | 663,822 | 3,735 | |
| Aug 13 2018 | JAZZ | Jazz Pharmaceutica ... | RIEDEL NORBERT G | Director | Sell | S | 176.61 | 660 | 116,563 | 6,491 | 7.2 K to 6.5 K (-9.23 %) |
| Aug 13 2018 | JAZZ | Jazz Pharmaceutica ... | RIEDEL NORBERT G | Director | Grant | A | 0.00 | 1,495 | 0 | 7,151 | 5.7 K to 7.2 K (+26.43 %) |
| Aug 13 2018 | JAZZ | Jazz Pharmaceutica ... | RIEDEL NORBERT G | Director | Option Exercise | A | 177.73 | 3,735 | 663,822 | 3,735 | |
| Aug 13 2018 | JAZZ | Jazz Pharmaceutica ... | RIEDEL NORBERT G | Director | Sell | S | 176.61 | 660 | 116,563 | 6,491 | 7.2 K to 6.5 K (-9.23 %) |
| Aug 13 2018 | JAZZ | Jazz Pharmaceutica ... | RIEDEL NORBERT G | Director | Grant | A | 0.00 | 1,495 | 0 | 7,151 | 5.7 K to 7.2 K (+26.43 %) |
| Jun 26 2018 | APTX | Aptinyx Inc. | RIEDEL NORBERT G | CEO and President | Option Exercise | C | 0.00 | 836,541 | 0 | 0 | |
| Jun 26 2018 | APTX | Aptinyx Inc. | RIEDEL NORBERT G | CEO and President | Option Exercise | C | 0.00 | 836,541 | 0 | 0 | |
| Jun 26 2018 | APTX | Aptinyx Inc. | RIEDEL NORBERT G | CEO and President | Option Exercise | C | 0.00 | 1,334,254 | 0 | 0 | |
| Jun 26 2018 | APTX | Aptinyx Inc. | RIEDEL NORBERT G | CEO and President | Option Exercise | C | 0.00 | 1,334,254 | 0 | 0 | |
| Jun 26 2018 | APTX | Aptinyx Inc. | RIEDEL NORBERT G | CEO and President | Option Exercise | C | 0.00 | 75,000 | 0 | 0 | |
| Jun 26 2018 | APTX | Aptinyx Inc. | RIEDEL NORBERT G | CEO and President | Option Exercise | C | 0.00 | 75,000 | 0 | 0 | |
| Jun 26 2018 | APTX | Aptinyx Inc. | RIEDEL NORBERT G | CEO and President | Option Exercise | C | 0.00 | 1,042,482 | 0 | 0 | |
| Jun 26 2018 | APTX | Aptinyx Inc. | RIEDEL NORBERT G | CEO and President | Option Exercise | C | 0.00 | 1,042,482 | 0 | 0 | |
| Jun 26 2018 | APTX | Aptinyx Inc. | RIEDEL NORBERT G | CEO and President | Buy | P | 16.00 | 2,400 | 38,400 | 5,118 | 2.7 K to 5.1 K (+88.30 %) |
| Jun 26 2018 | APTX | Aptinyx Inc. | RIEDEL NORBERT G | CEO and President | Buy | P | 16.00 | 2,400 | 38,400 | 5,118 | 2.7 K to 5.1 K (+88.30 %) |
| Jun 26 2018 | APTX | Aptinyx Inc. | RIEDEL NORBERT G | CEO and President | Buy | C | 0.00 | 2,718 | 0 | 2,718 | 0 to 2.7 K |
| Jun 26 2018 | APTX | Aptinyx Inc. | RIEDEL NORBERT G | CEO and President | Buy | C | 0.00 | 2,718 | 0 | 2,718 | 0 to 2.7 K |
| Jun 26 2018 | APTX | Aptinyx Inc. | RIEDEL NORBERT G | CEO and President | Buy | C | 0.00 | 30,324 | 0 | 323,976 | 293.7 K to 324 K (+10.33 %) |
| Jun 26 2018 | APTX | Aptinyx Inc. | RIEDEL NORBERT G | CEO and President | Buy | C | 0.00 | 30,324 | 0 | 323,976 | 293.7 K to 324 K (+10.33 %) |
| Jun 26 2018 | APTX | Aptinyx Inc. | RIEDEL NORBERT G | CEO and President | Buy | C | 0.00 | 48,367 | 0 | 293,652 | 245.3 K to 293.7 K (+19.72 %) |
| Jun 26 2018 | APTX | Aptinyx Inc. | RIEDEL NORBERT G | CEO and President | Buy | C | 0.00 | 48,367 | 0 | 293,652 | 245.3 K to 293.7 K (+19.72 %) |
| Jun 26 2018 | APTX | Aptinyx Inc. | RIEDEL NORBERT G | CEO and President | Buy | C | 0.00 | 37,790 | 0 | 245,285 | 207.5 K to 245.3 K (+18.21 %) |
| Jun 26 2018 | APTX | Aptinyx Inc. | RIEDEL NORBERT G | CEO and President | Buy | C | 0.00 | 37,790 | 0 | 245,285 | 207.5 K to 245.3 K (+18.21 %) |
| Aug 14 2017 | JAZZ | Jazz Pharmaceutica ... | RIEDEL NORBERT G | Director | Option Exercise | A | 143.66 | 3,415 | 490,599 | 3,415 | |
| Aug 14 2017 | JAZZ | Jazz Pharmaceutica ... | RIEDEL NORBERT G | Director | Sell | S | 144.13 | 3 | 432 | 5,656 | 5.7 K to 5.7 K (-0.05 %) |
| Aug 14 2017 | JAZZ | Jazz Pharmaceutica ... | RIEDEL NORBERT G | Director | Sell | S | 142.36 | 659 | 93,815 | 5,659 | 6.3 K to 5.7 K (-10.43 %) |
| Aug 14 2017 | JAZZ | Jazz Pharmaceutica ... | RIEDEL NORBERT G | Director | Grant | A | 0.00 | 1,365 | 0 | 6,318 | 5 K to 6.3 K (+27.56 %) |
| Feb 16 2017 | ARIA | ARIAD PHARMACEUTIC ... | RIEDEL NORBERT G | Director | Option Exercise | D | 23.82 | 25,000 | 595,500 | 0 | |
| Feb 16 2017 | ARIA | ARIAD PHARMACEUTIC ... | RIEDEL NORBERT G | Director | Option Exercise | D | 4.91 | 25,000 | 122,750 | 0 | |
| Feb 16 2017 | ARIA | ARIAD PHARMACEUTIC ... | RIEDEL NORBERT G | Director | Option Exercise | D | 6.45 | 25,000 | 161,250 | 0 | |
| Feb 16 2017 | ARIA | ARIAD PHARMACEUTIC ... | RIEDEL NORBERT G | Director | Option Exercise | D | 7.39 | 25,000 | 184,750 | 0 | |
| Feb 16 2017 | ARIA | ARIAD PHARMACEUTIC ... | RIEDEL NORBERT G | Director | Option Exercise | D | 8.50 | 25,000 | 212,500 | 0 | |
| Feb 16 2017 | ARIA | ARIAD PHARMACEUTIC ... | RIEDEL NORBERT G | Director | Sell | D | 0.00 | 139,867 | 0 | 0 | 139.9 K to 0 (-100.00 %) |
| Feb 01 2017 | ARIA | ARIAD PHARMACEUTIC ... | RIEDEL NORBERT G | Director | Option Exercise | A | 23.82 | 25,000 | 595,500 | 25,000 | |
| Feb 01 2017 | ARIA | ARIAD PHARMACEUTIC ... | RIEDEL NORBERT G | Director | Grant | A | 0.00 | 12,500 | 0 | 139,867 | 127.4 K to 139.9 K (+9.81 %) |
| Feb 01 2017 | ARIA | ARIAD PHARMACEUTIC ... | RIEDEL NORBERT G | Director | Grant | A | 0.00 | 5,508 | 0 | 127,367 | 121.9 K to 127.4 K (+4.52 %) |
| Aug 17 2016 | JAZZ | Jazz Pharmaceutica ... | RIEDEL NORBERT G | Director | Sell | S | 136.45 | 633 | 86,373 | 4,953 | 5.6 K to 5 K (-11.33 %) |
| Aug 15 2016 | JAZZ | Jazz Pharmaceutica ... | RIEDEL NORBERT G | Director | Option Exercise | A | 138.08 | 3,415 | 471,543 | 3,415 | |
| Aug 15 2016 | JAZZ | Jazz Pharmaceutica ... | RIEDEL NORBERT G | Director | Grant | A | 0.00 | 1,365 | 0 | 5,586 | 4.2 K to 5.6 K (+32.34 %) |
| May 17 2016 | JAZZ | Jazz Pharmaceutica ... | RIEDEL NORBERT G | Director | Sell | S | 145.20 | 644 | 93,509 | 4,221 | 4.9 K to 4.2 K (-13.24 %) |
| Feb 03 2016 | ARIA | ARIAD PHARMACEUTIC ... | RIEDEL NORBERT G | Director | Option Exercise | A | 0.00 | 25,000 | 0 | 25,000 | |
| Feb 03 2016 | ARIA | ARIAD PHARMACEUTIC ... | RIEDEL NORBERT G | Director | Grant | A | 0.00 | 12,500 | 0 | 121,859 | 109.4 K to 121.9 K (+11.43 %) |
| Aug 11 2015 | JAZZ | Jazz Pharmaceutica ... | RIEDEL NORBERT G | Director | Option Exercise | A | 181.79 | 3,415 | 620,813 | 3,415 | |
| Aug 11 2015 | JAZZ | Jazz Pharmaceutica ... | RIEDEL NORBERT G | Director | Sell | S | 183.36 | 4 | 733 | 4,865 | 4.9 K to 4.9 K (-0.08 %) |
| Aug 11 2015 | JAZZ | Jazz Pharmaceutica ... | RIEDEL NORBERT G | Director | Sell | S | 179.98 | 797 | 143,444 | 4,869 | 5.7 K to 4.9 K (-14.07 %) |
| Aug 11 2015 | JAZZ | Jazz Pharmaceutica ... | RIEDEL NORBERT G | Director | Grant | A | 0.00 | 1,310 | 0 | 5,666 | 4.4 K to 5.7 K (+30.07 %) |
| May 14 2015 | JAZZ | Jazz Pharmaceutica ... | RIEDEL NORBERT G | Director | Sell | S | 175.10 | 6 | 1,051 | 4,356 | 4.4 K to 4.4 K (-0.14 %) |
| May 14 2015 | JAZZ | Jazz Pharmaceutica ... | RIEDEL NORBERT G | Director | Sell | S | 173.85 | 644 | 111,959 | 4,362 | 5 K to 4.4 K (-12.86 %) |
| Jan 18 2013 | BAX | BAXTER INTERNATION ... | RIEDEL NORBERT G | Corporate Vice Pres ... | Payment of Exercise | F | 66.52 | 1,925 | 128,051 | 56,689 | 58.6 K to 56.7 K (-3.28 %) |
| Jan 18 2013 | BAX | BAXTER INTERNATION ... | RIEDEL NORBERT G | Corporate Vice Pres ... | Grant | A | 0.00 | 5,799 | 0 | 58,614 | 52.8 K to 58.6 K (+10.98 %) |
| Aug 06 2012 | BAX | BAXTER INTERNATION ... | RIEDEL NORBERT G | Corporate Vice Pres ... | Option Exercise | M | 38.35 | 70,125 | 2,689,294 | 0 | |
| Aug 06 2012 | BAX | BAXTER INTERNATION ... | RIEDEL NORBERT G | Corporate Vice Pres ... | Sell | S | 58.99 | 70,125 | 4,136,674 | 52,815 | 122.9 K to 52.8 K (-57.04 %) |
| Aug 06 2012 | BAX | BAXTER INTERNATION ... | RIEDEL NORBERT G | Corporate Vice Pres ... | Buy | M | 38.35 | 70,125 | 2,689,294 | 122,940 | 52.8 K to 122.9 K (+132.77 %) |
| Mar 08 2012 | BAX | BAXTER INTERNATION ... | RIEDEL NORBERT G | Corporate Vice Pres ... | Option Exercise | A | 57.48 | 36,048 | 2,072,039 | 36,048 | |
| Mar 08 2011 | BAX | BAXTER INTERNATION ... | RIEDEL NORBERT G | Corporate Vice Pres ... | Option Exercise | A | 53.80 | 36,346 | 1,955,415 | 36,346 | |
| Jan 21 2011 | BAX | BAXTER INTERNATION ... | RIEDEL NORBERT G | Corporate Vice Pres ... | Payment of Exercise | F | 50.30 | 1,096 | 55,129 | 51,970 | 53.1 K to 52 K (-2.07 %) |
| Jan 21 2011 | BAX | BAXTER INTERNATION ... | RIEDEL NORBERT G | Corporate Vice Pres ... | Grant | A | 0.00 | 3,302 | 0 | 53,066 | 49.8 K to 53.1 K (+6.64 %) |
| Mar 17 2010 | BAX | BAXTER INTERNATION ... | RIEDEL NORBERT G | Corporate Vice Pres ... | Payment of Exercise | F | 58.37 | 763 | 44,536 | 49,485 | 50.2 K to 49.5 K (-1.52 %) |
| Mar 09 2010 | BAX | BAXTER INTERNATION ... | RIEDEL NORBERT G | Corporate Vice Pres ... | Option Exercise | M | 49.54 | 75,600 | 3,745,224 | 0 | |
| Mar 09 2010 | BAX | BAXTER INTERNATION ... | RIEDEL NORBERT G | Corporate Vice Pres ... | Sell | S | 59.29 | 75,600 | 4,482,324 | 50,248 | 125.8 K to 50.2 K (-60.07 %) |
| Mar 09 2010 | BAX | BAXTER INTERNATION ... | RIEDEL NORBERT G | Corporate Vice Pres ... | Buy | M | 49.54 | 75,600 | 3,745,224 | 125,848 | 50.2 K to 125.8 K (+150.45 %) |
| Mar 05 2010 | BAX | BAXTER INTERNATION ... | RIEDEL NORBERT G | Corporate Vice Pres ... | Option Exercise | A | 59.00 | 31,523 | 1,859,857 | 31,523 | |
| Jan 22 2010 | BAX | BAXTER INTERNATION ... | RIEDEL NORBERT G | Corporate Vice Pres ... | Payment of Exercise | F | 60.80 | 6,323 | 384,438 | 50,101 | 56.4 K to 50.1 K (-11.21 %) |
| Jan 22 2010 | BAX | BAXTER INTERNATION ... | RIEDEL NORBERT G | Corporate Vice Pres ... | Grant | A | 0.00 | 20,000 | 0 | 56,424 | 36.4 K to 56.4 K (+54.91 %) |
| Dec 04 2009 | BAX | BAXTER INTERNATION ... | RIEDEL NORBERT G | Corporate Vice Pres ... | Option Exercise | M | 34.85 | 82,500 | 2,875,125 | 0 | |
| Dec 04 2009 | BAX | BAXTER INTERNATION ... | RIEDEL NORBERT G | Corporate Vice Pres ... | Option Exercise | M | 27.13 | 10,000 | 271,300 | 0 | |
| Dec 04 2009 | BAX | BAXTER INTERNATION ... | RIEDEL NORBERT G | Corporate Vice Pres ... | Sell | S | 55.92 | 92,500 | 5,172,600 | 36,424 | 128.9 K to 36.4 K (-71.75 %) |
| Dec 04 2009 | BAX | BAXTER INTERNATION ... | RIEDEL NORBERT G | Corporate Vice Pres ... | Buy | M | 34.85 | 82,500 | 2,875,125 | 128,924 | 46.4 K to 128.9 K (+177.71 %) |
| Dec 04 2009 | BAX | BAXTER INTERNATION ... | RIEDEL NORBERT G | Corporate Vice Pres ... | Buy | M | 27.13 | 10,000 | 271,300 | 46,424 | 36.4 K to 46.4 K (+27.45 %) |
| Mar 18 2009 | BAX | BAXTER INTERNATION ... | RIEDEL NORBERT G | Corporate Vice Pres ... | Payment of Exercise | F | 51.07 | 763 | 38,966 | 36,143 | 36.9 K to 36.1 K (-2.07 %) |
| Mar 18 2009 | BAX | BAXTER INTERNATION ... | RIEDEL NORBERT G | Corporate Vice Pres ... | Payment of Exercise | F | 51.07 | 1,342 | 68,536 | 36,906 | 38.2 K to 36.9 K (-3.51 %) |
| Mar 06 2009 | BAX | BAXTER INTERNATION ... | RIEDEL NORBERT G | Corporate Vice Pres ... | Option Exercise | A | 52.50 | 27,510 | 1,444,275 | 27,510 | |
| Jan 28 2009 | BAX | BAXTER INTERNATION ... | RIEDEL NORBERT G | Corporate Vice Pres ... | Option Exercise | M | 41.34 | 54,300 | 2,244,968 | 0 | |
| Jan 28 2009 | BAX | BAXTER INTERNATION ... | RIEDEL NORBERT G | Corporate Vice Pres ... | Option Exercise | M | 41.34 | 10,500 | 434,110 | 0 | |
| Jan 28 2009 | BAX | BAXTER INTERNATION ... | RIEDEL NORBERT G | Corporate Vice Pres ... | Option Exercise | M | 41.34 | 15,200 | 628,426 | 0 | |
| Jan 28 2009 | BAX | BAXTER INTERNATION ... | RIEDEL NORBERT G | Corporate Vice Pres ... | Option Exercise | M | 41.34 | 22,300 | 921,967 | 15,200 | |
| Jan 28 2009 | BAX | BAXTER INTERNATION ... | RIEDEL NORBERT G | Corporate Vice Pres ... | Sell | S | 58.09 | 54,300 | 3,154,287 | 38,099 | 92.4 K to 38.1 K (-58.77 %) |
| Jan 28 2009 | BAX | BAXTER INTERNATION ... | RIEDEL NORBERT G | Corporate Vice Pres ... | Buy | M | 41.34 | 54,300 | 2,244,762 | 92,399 | 38.1 K to 92.4 K (+142.52 %) |
| Jan 28 2009 | BAX | BAXTER INTERNATION ... | RIEDEL NORBERT G | Corporate Vice Pres ... | Sell | S | 58.09 | 10,500 | 609,945 | 38,099 | 48.6 K to 38.1 K (-21.61 %) |
| Jan 28 2009 | BAX | BAXTER INTERNATION ... | RIEDEL NORBERT G | Corporate Vice Pres ... | Buy | M | 41.34 | 10,500 | 434,070 | 48,599 | 38.1 K to 48.6 K (+27.56 %) |
| Jan 28 2009 | BAX | BAXTER INTERNATION ... | RIEDEL NORBERT G | Corporate Vice Pres ... | Sell | S | 58.09 | 15,200 | 882,968 | 38,099 | 53.3 K to 38.1 K (-28.52 %) |
| Jan 28 2009 | BAX | BAXTER INTERNATION ... | RIEDEL NORBERT G | Corporate Vice Pres ... | Buy | M | 41.34 | 15,200 | 628,368 | 53,299 | 38.1 K to 53.3 K (+39.90 %) |
| Jan 28 2009 | BAX | BAXTER INTERNATION ... | RIEDEL NORBERT G | Corporate Vice Pres ... | Sell | S | 58.00 | 22,300 | 1,293,400 | 38,099 | 60.4 K to 38.1 K (-36.92 %) |
| Jan 28 2009 | BAX | BAXTER INTERNATION ... | RIEDEL NORBERT G | Corporate Vice Pres ... | Buy | M | 41.34 | 22,300 | 921,882 | 60,399 | 38.1 K to 60.4 K (+58.53 %) |
| Mar 18 2008 | BAX | BAXTER INTERNATION ... | RIEDEL NORBERT G | Corporate Vice Pres ... | Payment of Exercise | F | 55.41 | 570 | 31,584 | 37,799 | 38.4 K to 37.8 K (-1.49 %) |
| Mar 18 2008 | BAX | BAXTER INTERNATION ... | RIEDEL NORBERT G | Corporate Vice Pres ... | Payment of Exercise | F | 56.27 | 1,002 | 56,383 | 38,369 | 39.4 K to 38.4 K (-2.55 %) |
| Mar 18 2008 | BAX | BAXTER INTERNATION ... | RIEDEL NORBERT G | Corporate Vice Pres ... | Payment of Exercise | F | 56.27 | 1,178 | 66,286 | 39,371 | 40.5 K to 39.4 K (-2.91 %) |
| Mar 07 2008 | BAX | BAXTER INTERNATION ... | RIEDEL NORBERT G | Corporate Vice Pres ... | Option Exercise | A | 58.12 | 30,450 | 1,769,754 | 30,450 | |
| Mar 16 2005 | BAX | BAXTER INTERNATION ... | RIEDEL NORBERT G | Corporate Vice Pres ... | Option Exercise | A | 34.85 | 82,500 | 2,875,125 | 82,500 | |
| Mar 16 2005 | BAX | BAXTER INTERNATION ... | RIEDEL NORBERT G | Corporate Vice Pres ... | Grant | A | 0.00 | 12,000 | 0 | 27,247 | 15.2 K to 27.2 K (+78.70 %) |
| Nov 20 2003 | BAX | BAXTER INTERNATION ... | RIEDEL NORBERT G | Senior Vice Preside ... | Option Exercise | A | 27.13 | 43,200 | 1,172,016 | 43,200 |
Page: 1